vs
Side-by-side financial comparison of BADGER METER INC (BMI) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
BADGER METER INC is the larger business by last-quarter revenue ($234.1M vs $164.7M, roughly 1.4× PTC THERAPEUTICS, INC.). BADGER METER INC runs the higher net margin — 14.3% vs -82.0%, a 96.3% gap on every dollar of revenue. On growth, BADGER METER INC posted the faster year-over-year revenue change (14.1% vs -22.7%). BADGER METER INC produced more free cash flow last quarter ($50.8M vs $-36.6M). Over the past eight quarters, BADGER METER INC's revenue compounded faster (9.2% CAGR vs -11.5%).
Badger Meter Inc. is a leading global provider of flow measurement and control solutions, serving water utilities, industrial, commercial, and residential customer segments. Its core offerings include smart water meters, IoT-enabled usage monitoring systems, and supporting software that help clients track resource consumption, cut waste, and boost operational efficiency, with key markets spanning North America, Europe, and the Asia-Pacific region.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
BMI vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $234.1M | $164.7M |
| Net Profit | $33.6M | $-135.0M |
| Gross Margin | 39.7% | — |
| Operating Margin | 18.4% | -43.3% |
| Net Margin | 14.3% | -82.0% |
| Revenue YoY | 14.1% | -22.7% |
| Net Profit YoY | 9.3% | -104.8% |
| EPS (diluted) | $1.13 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $234.1M | $164.7M | ||
| Q3 25 | $222.2M | $211.0M | ||
| Q2 25 | $238.1M | $178.9M | ||
| Q1 25 | $222.2M | $1.2B | ||
| Q4 24 | $205.2M | $213.2M | ||
| Q3 24 | $208.4M | $196.8M | ||
| Q2 24 | $216.7M | $186.7M | ||
| Q1 24 | $196.3M | $210.1M |
| Q4 25 | $33.6M | $-135.0M | ||
| Q3 25 | $35.1M | $15.9M | ||
| Q2 25 | $34.6M | $-64.8M | ||
| Q1 25 | $38.4M | $866.6M | ||
| Q4 24 | $30.7M | $-65.9M | ||
| Q3 24 | $32.0M | $-106.7M | ||
| Q2 24 | $33.1M | $-99.2M | ||
| Q1 24 | $29.1M | $-91.6M |
| Q4 25 | 39.7% | — | ||
| Q3 25 | 43.1% | — | ||
| Q2 25 | 41.1% | — | ||
| Q1 25 | 42.9% | — | ||
| Q4 24 | 40.3% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | 39.4% | — | ||
| Q1 24 | 39.3% | — |
| Q4 25 | 18.4% | -43.3% | ||
| Q3 25 | 20.7% | 1.4% | ||
| Q2 25 | 18.8% | -19.5% | ||
| Q1 25 | 22.2% | 82.5% | ||
| Q4 24 | 19.1% | -76.2% | ||
| Q3 24 | 19.5% | -27.7% | ||
| Q2 24 | 19.2% | -21.5% | ||
| Q1 24 | 18.6% | -21.6% |
| Q4 25 | 14.3% | -82.0% | ||
| Q3 25 | 15.8% | 7.5% | ||
| Q2 25 | 14.5% | -36.3% | ||
| Q1 25 | 17.3% | 73.7% | ||
| Q4 24 | 15.0% | -30.9% | ||
| Q3 24 | 15.4% | -54.2% | ||
| Q2 24 | 15.3% | -53.1% | ||
| Q1 24 | 14.8% | -43.6% |
| Q4 25 | $1.13 | $-1.63 | ||
| Q3 25 | $1.19 | $0.20 | ||
| Q2 25 | $1.17 | $-0.83 | ||
| Q1 25 | $1.30 | $10.04 | ||
| Q4 24 | $1.04 | $-0.85 | ||
| Q3 24 | $1.08 | $-1.39 | ||
| Q2 24 | $1.12 | $-1.29 | ||
| Q1 24 | $0.99 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $713.3M | $-205.3M |
| Total Assets | $973.6M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $884.8M |
| Q4 25 | $713.3M | $-205.3M | ||
| Q3 25 | $702.5M | $-155.8M | ||
| Q2 25 | $677.6M | $-206.5M | ||
| Q1 25 | $641.7M | $-185.8M | ||
| Q4 24 | $606.2M | $-1.1B | ||
| Q3 24 | $591.2M | $-1.1B | ||
| Q2 24 | $563.1M | $-980.2M | ||
| Q1 24 | $535.6M | $-893.9M |
| Q4 25 | $973.6M | $2.9B | ||
| Q3 25 | $978.3M | $2.6B | ||
| Q2 25 | $936.4M | $2.6B | ||
| Q1 25 | $899.6M | $2.7B | ||
| Q4 24 | $816.4M | $1.7B | ||
| Q3 24 | $802.9M | $1.8B | ||
| Q2 24 | $781.3M | $1.9B | ||
| Q1 24 | $743.5M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $54.8M | $-34.3M |
| Free Cash FlowOCF − Capex | $50.8M | $-36.6M |
| FCF MarginFCF / Revenue | 21.7% | -22.3% |
| Capex IntensityCapex / Revenue | 1.7% | 1.4% |
| Cash ConversionOCF / Net Profit | 1.63× | — |
| TTM Free Cash FlowTrailing 4 quarters | $169.7M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $54.8M | $-34.3M | ||
| Q3 25 | $51.3M | $-66.3M | ||
| Q2 25 | $44.6M | $-58.3M | ||
| Q1 25 | $33.0M | $870.1M | ||
| Q4 24 | $52.1M | $-30.0M | ||
| Q3 24 | $45.1M | $-77.0M | ||
| Q2 24 | $36.4M | $-71.5M | ||
| Q1 24 | $21.5M | $70.8M |
| Q4 25 | $50.8M | $-36.6M | ||
| Q3 25 | $48.2M | $-69.7M | ||
| Q2 25 | $40.6M | $-59.6M | ||
| Q1 25 | $30.1M | $868.4M | ||
| Q4 24 | $47.4M | $-33.8M | ||
| Q3 24 | $42.0M | $-77.5M | ||
| Q2 24 | $34.1M | $-78.8M | ||
| Q1 24 | $18.8M | $61.2M |
| Q4 25 | 21.7% | -22.3% | ||
| Q3 25 | 21.7% | -33.1% | ||
| Q2 25 | 17.1% | -33.3% | ||
| Q1 25 | 13.5% | 73.8% | ||
| Q4 24 | 23.1% | -15.8% | ||
| Q3 24 | 20.1% | -39.4% | ||
| Q2 24 | 15.7% | -42.2% | ||
| Q1 24 | 9.6% | 29.1% |
| Q4 25 | 1.7% | 1.4% | ||
| Q3 25 | 1.4% | 1.6% | ||
| Q2 25 | 1.7% | 0.7% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 2.3% | 1.8% | ||
| Q3 24 | 1.5% | 0.3% | ||
| Q2 24 | 1.1% | 4.0% | ||
| Q1 24 | 1.4% | 4.6% |
| Q4 25 | 1.63× | — | ||
| Q3 25 | 1.46× | -4.17× | ||
| Q2 25 | 1.29× | — | ||
| Q1 25 | 0.86× | 1.00× | ||
| Q4 24 | 1.70× | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | 0.74× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BMI
| Transferred At Point In Time | $198.6M | 85% |
| Transferred Over Time | $22.1M | 9% |
| Other | $13.4M | 6% |
PTCT
Segment breakdown not available.
